Analysts Anticipate Syneos Well being, Inc. (NASDAQ:SYNH) to Announce $0.97 Earnings Per Share

Analysts anticipate Syneos Well being, Inc. (NASDAQ:SYNH – Get Score) to announce $0.97 earnings per share for the present quarter, in keeping with Zacks. 4 analysts have issued estimates for Syneos Well being’s earnings, with the very best EPS estimate coming in at $0.99 and the bottom estimate coming in at $0.95. Syneos Well being posted earnings of $0.79 per share throughout the identical quarter final 12 months, which might point out a optimistic year-over-year development price of twenty-two.8%. The corporate is scheduled to situation its subsequent earnings report on Thursday, Could fifth.

Based on Zacks, analysts anticipate that Syneos Well being will report full-year earnings of $5.15 per share for the present monetary 12 months, with EPS estimates starting from $5.12 to $5.17. For the following fiscal 12 months, analysts anticipate that the corporate will report earnings of $5.81 per share, with EPS estimates starting from $5.76 to $5.89. Zacks’ EPS calculations are a mean primarily based on a survey of sell-side analysis companies that cowl Syneos Well being.

Syneos Well being (NASDAQ:SYNH – Get Score) final launched its quarterly earnings knowledge on Thursday, February seventeenth. The corporate reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.43 by $0.05. The corporate had income of $1.37 billion in the course of the quarter, in comparison with analysts’ expectations of $1.40 billion. Syneos Well being had a internet margin of 5.04% and a return on fairness of 11.71%. The agency’s quarterly income was up 20.5% on a year-over-year foundation. Throughout the identical interval within the earlier 12 months, the corporate earned $1.00 EPS.

3 Stocks Set to Double

A number of equities analysis analysts have issued reviews on the inventory. Citigroup minimize shares of Syneos Well being from a “purchase” ranking to a “impartial” ranking and lowered their worth goal for the corporate from $115.00 to $105.00 in a analysis report on Wednesday, December fifteenth. Barclays lowered their worth goal on shares of Syneos Well being from $115.00 to $105.00 and set an “chubby” ranking for the corporate in a analysis report on Thursday, January twenty seventh. Lastly, Zacks Funding Analysis raised shares of Syneos Well being from a “promote” ranking to a “maintain” ranking and set a $95.00 worth goal for the corporate in a analysis report on Monday, January seventeenth. Two analysis analysts have rated the inventory with a maintain ranking and 5 have assigned a purchase ranking to the corporate. Primarily based on knowledge from MarketBeat, Syneos Well being has a consensus ranking of “Purchase” and a consensus goal worth of $103.14.

In associated information, CAO Donna Hildebrand Kralowetz bought 1,055 shares of the inventory in a transaction that occurred on Monday, January thirty first. The shares have been bought at a mean worth of $90.00, for a complete transaction of $94,950.00. The transaction was disclosed in a authorized submitting with the Securities & Change Fee, which is accessible by means of this hyperlink. Additionally, Normal Counsel Jonathan Olefson bought 1,889 shares of the inventory in a transaction that occurred on Thursday, December twenty third. The shares have been bought at a mean worth of $100.95, for a complete transaction of $190,694.55. The disclosure for this sale could be discovered right here. Insiders have bought 7,159 shares of firm inventory valued at $694,768 within the final three months. 0.29% of the inventory is at the moment owned by company insiders.

Institutional traders have not too long ago modified their holdings of the enterprise. Oregon Public Workers Retirement Fund elevated its stake in Syneos Well being by 13.4% in the course of the third quarter. Oregon Public Workers Retirement Fund now owns 34,632 shares of the corporate’s inventory valued at $3,030,000 after buying an extra 4,081 shares within the final quarter. Folks s United Monetary Inc. elevated its stake in Syneos Well being by 5.6% in the course of the third quarter. Folks s United Monetary Inc. now owns 12,867 shares of the corporate’s inventory valued at $1,126,000 after buying an extra 685 shares within the final quarter. Strs Ohio elevated its stake in Syneos Well being by 148.8% in the course of the third quarter. Strs Ohio now owns 380,620 shares of the corporate’s inventory valued at $33,296,000 after buying an extra 227,615 shares within the final quarter. Versor Investments LP acquired a brand new place in Syneos Well being in the course of the third quarter valued at roughly $341,000. Lastly, AMI Asset Administration Corp elevated its stake in Syneos Well being by 4.5% in the course of the third quarter. AMI Asset Administration Corp now owns 94,683 shares of the corporate’s inventory valued at $8,283,000 after buying an extra 4,106 shares within the final quarter. Institutional traders and hedge funds personal 95.03% of the corporate’s inventory.

Syneos Well being inventory opened at $79.35 on Thursday. The inventory has a market cap of $8.27 billion, a price-to-earnings ratio of 33.20 and a beta of 1.76. The corporate has a debt-to-equity ratio of 0.88, a present ratio of 1.04 and a fast ratio of 1.04. Syneos Well being has a 1 12 months low of $69.53 and a 1 12 months excessive of $104.18. The agency has a 50-day shifting common of $88.56 and a two-hundred day shifting common of $92.52.

Syneos Well being Firm Profile (Get Score)

Syneos Well being, Inc engages within the provision of outsourced scientific improvement and commercialization providers to biopharmaceutical firms. It operates by means of the next enterprise segments: Scientific Options and Business Options. The Scientific Options phase provides scientific improvement providers spanning Part I to Part IV, together with international research, in addition to unbundled service choices equivalent to scientific monitoring, investigator recruitment, affected person recruitment, knowledge administration, and examine startup to help prospects with their drug improvement course of.

See Additionally

Get a free copy of the Zacks analysis report on Syneos Well being (SYNH)

For extra details about analysis choices from Zacks Funding Analysis, go to Zacks.com

Earnings History and Estimates for Syneos Health (NASDAQ:SYNH)

Need Extra Nice Investing Concepts?

Obtain Information & Rankings for Syneos Well being Day by day – Enter your e-mail tackle under to obtain a concise every day abstract of the newest information and analysts’ rankings for Syneos Well being and associated firms with MarketBeat.com’s FREE every day e-mail e-newsletter.

Previous post Enrollees in medical insurance units report in Maryland | Maryland
Next post Does CBD Present up on Drug Checks?